BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 12058613)

  • 1. Progress in computational methods for the prediction of ADMET properties.
    Clark DE; Grootenhuis PD
    Curr Opin Drug Discov Devel; 2002 May; 5(3):382-90. PubMed ID: 12058613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Building predictive ADMET models for early decisions in drug discovery.
    Penzotti JE; Landrum GA; Putta S
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of ADMET Properties.
    Norinder U; Bergström CA
    ChemMedChem; 2006 Sep; 1(9):920-37. PubMed ID: 16952133
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improving compound quality through in vitro and in silico physicochemical profiling.
    van de Waterbeemd H
    Chem Biodivers; 2009 Nov; 6(11):1760-6. PubMed ID: 19937820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Using open source computational tools for predicting human metabolic stability and additional absorption, distribution, metabolism, excretion, and toxicity properties.
    Gupta RR; Gifford EM; Liston T; Waller CL; Hohman M; Bunin BA; Ekins S
    Drug Metab Dispos; 2010 Nov; 38(11):2083-90. PubMed ID: 20693417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In silico prediction of ADME properties: are we making progress?
    Beresford AP; Segall M; Tarbit MH
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):36-42. PubMed ID: 14982146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting ADME properties and side effects: the BioPrint approach.
    Krejsa CM; Horvath D; Rogalski SL; Penzotti JE; Mao B; Barbosa F; Migeon JC
    Curr Opin Drug Discov Devel; 2003 Jul; 6(4):470-80. PubMed ID: 12951810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive models for oral drug absorption: from in silico methods to integrated dynamical models.
    Dokoumetzidis A; Kalantzi L; Fotaki N
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):491-505. PubMed ID: 17696801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances in physicochemical and ADMET profiling in drug discovery.
    Wang J; Skolnik S
    Chem Biodivers; 2009 Nov; 6(11):1887-99. PubMed ID: 19937823
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prediction of human pharmacokinetics--gut-wall metabolism.
    Fagerholm U
    J Pharm Pharmacol; 2007 Oct; 59(10):1335-43. PubMed ID: 17910807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular models for ADMET predictions and evaluation of drug-drug interactions.
    Riley RJ; Kenna JG
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):86-99. PubMed ID: 14982152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gaussian processes for classification: QSAR modeling of ADMET and target activity.
    Obrezanova O; Segall MD
    J Chem Inf Model; 2010 Jun; 50(6):1053-61. PubMed ID: 20433177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of human pharmacokinetics--gastrointestinal absorption.
    Fagerholm U
    J Pharm Pharmacol; 2007 Jul; 59(7):905-16. PubMed ID: 17637184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward in silico structure-based ADMET prediction in drug discovery.
    Moroy G; Martiny VY; Vayer P; Villoutreix BO; Miteva MA
    Drug Discov Today; 2012 Jan; 17(1-2):44-55. PubMed ID: 22056716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Computational approaches to modeling drug transporters.
    Chang C; Swaan PW
    Eur J Pharm Sci; 2006 Apr; 27(5):411-24. PubMed ID: 16274971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A combined approach to drug metabolism and toxicity assessment.
    Ekins S; Andreyev S; Ryabov A; Kirillov E; Rakhmatulin EA; Sorokina S; Bugrim A; Nikolskaya T
    Drug Metab Dispos; 2006 Mar; 34(3):495-503. PubMed ID: 16381662
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Computational science in drug metabolism and toxicology.
    Valerio LG
    Expert Opin Drug Metab Toxicol; 2010 Jul; 6(7):781-4. PubMed ID: 20465524
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating molecular properties and in vitro assay results to in vivo drug disposition and toxicity outcomes.
    Sutherland JJ; Raymond JW; Stevens JL; Baker TK; Watson DE
    J Med Chem; 2012 Jul; 55(14):6455-66. PubMed ID: 22716080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fragment analysis in small molecule discovery.
    Merlot C; Domine D; Church DJ
    Curr Opin Drug Discov Devel; 2002 May; 5(3):391-9. PubMed ID: 12058614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimizing the performance of in silico ADMET general models according to local requirements: MARS approach. solubility estimations as case study.
    Oyarzabal J; Pastor J; Howe TJ
    J Chem Inf Model; 2009 Dec; 49(12):2837-50. PubMed ID: 19919041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.